Meal Replacement System

Meal replacement system for Type 2 Diabetes

Loma Linda University Health, Loma Linda, CA
Targeting 2 different conditionsMeal replacement system +1 moreN/ARecruitingLed by Warren Peters, MDResearch Sponsored by Loma Linda University

Study Summary

This trial is testing a meal replacement system to see if it can help people with Type 2 Diabetes go into remission without the use of medications.

Eligible Conditions
  • Type 2 Diabetes
  • Obesity

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are taking medication for diabetes by mouth.
Both men and women.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and six month visit.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and six month visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of plant-based meal replacement system on A1-C levels
Secondary outcome measures
Efficacy of plant-based meal replacement system on insulin levels

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
Replace meals with a plant-based meal replacement and self-prepared Meditteranean meals for a max 1200 calorie per day. Enroll in a 12 week intensive lifestyle intervention program.
Group II: Standard of Care GroupActive Control1 Intervention

Find a site

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
293 Previous Clinical Trials
258,099 Total Patients Enrolled
Warren Peters, MDPrincipal Investigator
Loma Linda University Health
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Proprietary Meal Replacement System (Meal Replacement System) Clinical Trial Eligibility Overview. Trial Name: NCT05397028 — N/A
Type 2 Diabetes Research Study Groups: Intervention Group, Standard of Care Group
Type 2 Diabetes Clinical Trial 2023: Proprietary Meal Replacement System Highlights & Side Effects. Trial Name: NCT05397028 — N/A
Proprietary Meal Replacement System (Meal Replacement System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05397028 — N/A
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT05397028 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of individuals taking part in this research?

"Affirmative. According to records accessible via, this medical trial is continuing its recruitment efforts having been initially posted on August 1st 2022 and last updated on June 28th 2022. As of now, the study requires 50 people from one site."

Answered by AI

What criteria must potential participants meet to be qualified for inclusion in this study?

"This research requires 50 participants aged between 25-65 who suffer from type 2 diabetes mellitus, as well as being male or female and having had the condition for no more than five years. Additionally, it is requisite that all subjects take oral agents to manage their medical condition and are able to converse in English."

Answered by AI

Are individuals over the age of 55 able to participate in this experiment?

"This current trial is enrolling individuals aged 25 and over, but under 65 years old."

Answered by AI

Are there any available slots for participants in this clinical trial?

"Affirmative. According to information publicly available on, this medical trial is currently accepting applications from participants. The study was initially published on August 1st 2022 and has since been updated as of June 28th 2022; 50 individuals are needed across a single location for enrolment purposes."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
What site did they apply to?
Loma Linda University Health
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Interested in finding non-medication-based treatment for diabetes 2 and obesity.
~33 spots leftby Mar 2026